CHARACTERISTICS OF BACTERIOLOGICAL CAUSES OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE AT KIEN GIANG PROVINCE GENERAL HOSPITAL IN 2020

Tran Ai Linh Ngo1,, Thi Linh Tuyen Nguyen2, Hoang Lam Tran3, Thi Yen Nhi Vo1
1 Kien Giang Medical College
2 Can Tho University of Medicine and Pharmacy
3 Kien Giang University

Main Article Content

Abstract

Background: Exacerbations of chronic obstructive pulmonary disease (COPD) lead to hospitalization and death in COPD patients, with infectious causes accounting for 70-80%. Therefore, microbiological assessment to help choose the right antibiotic in the treatment of this disease is very important and has clinical significance. Objectives: 1. Describe the characteristics of pathogenic bacteria causing acute exacerbations of COPD at Kien Giang province General Hospital in 2020. 2. Investigate some related factors to infection with some common bacterial strains causing exacerbations of chronic obstructive pulmonary disease. Materials and methods: A crosssectional descriptive study was conducted on 400 medical records of COPD exacerbations were admitted to hospital for treatment at the Department of Respiratory Internal Medicine at Kien Giang General Hospital in 2020. Data processing method is using SPSS software. Results: COPD exacerbations caused by Gram-negative bacteria account for the majority (79.71%). Some common strains are Klebsiella ssp. (27.54%), Pseudomonas ssp. (20.29%) and Acinetobacter baumannii (17.39%). Klebsiella ssp. are highly resistant to cephalosporin, Pseudomonas ssp. are highly resistant to gentamycin and carbapenems; Acinetobacter baumannii are resistant to ciprofloxacin and cephalosporins. Gram-positive bacteria account for 20.29%. The most common strain is Streptococcus pneumonia (11.59%).They are highly resistant to betalactam. Some factors related to the risk of infection is not smoking reduces the risk of infection with Klebsiella spp. (OR = 0.02, p = 0.016). The risk of infection with Pseudomonas spp. is reduced in the absence of hypertension (OR = 0.067, p = 0.040), type 2 diabetes (OR = 0.11, p = 0.011), old pulmonary tuberculosis (OR = 0.11, p = 0.003). Conclusion: The majority of pathogenic bacteria are gram-negative. Common strains are Klebsiella ssp., Pseudomonas ssp., Streptococcus ssp., Acinetobacter baumannii.  Some factors related to the risk of infection such as smoking, having old tuberculosis, having hypertension, having type 2 diabetes.

Article Details

References

1. Lê Tiến Dũng (2016), “Vi khuẩn gây đợt kịch phát COPD nhiễm khuẩn nhập viện”, Tạp chí Y học TP Hồ Chí Minh, Vol 2(20), tr.259-262.
2. Nguyễn Văn Đồng (2020), “Kháng sinh trong đợt cấp bệnh phổi tắc nghẽn mãn tính tại bệnh viện phổi Hưng Yên”, Luận văn Dược sĩ chuyên khoa cấp 1, Đại học Dược Hà Nội.
3. Nguyễn Phú Hương Lan (2010), “Khảo sát mức độ đề kháng kháng sinh của Acinetobacter và Pseudomonas phân lập tại Bệnh viện Bệnh Nhiệt Đới”, thời sự Y học, số 68, tr.9, 3/2012.
4. Trần Văn Ngọc và cộng sự (2017), “Khảo sát đặc điểm kháng thuốc của pseudomonas aeruginosa và acinetobacter baumannii gây viêm phổi bệnh viện”, thời sự Y học, tr.64, 3/2012
5. Phạm Hồng Nhung và cộng sự (2013), “Mức độ nhạy cảm của kháng sinh với các trực khuẩn gram âm phân lập tại khoa điều trị bệnh viện Bạch Mai”, Tạp chí Nghiên cứu Y học, 109 (4), tr.1-8.
6. Phạm Hùng Vân và Nhóm nghiên cứu Midas (2010), “Nghiên cứu đa trung tâm về tình hình đề kháng kháng sinh của trực trùng Gram âm dễ mọc kết quả trên 16 bệnh viện tại Việt Nam”, Tạp chí Y học Thành phố Hồ Chí Minh, tập 14 (số 2).
7. Aydemir Y.,et al. (2014), “Relationship between the GOLD combined COPD assessment staging system and bacterial isolation”, Int J Chron Obstruct Pulmon Dis, 9, pp.1045-51
8. Borja G. Cosio, Alvar Agusti (2016) “Update in chronic obtructive pulmonary disease 2015”. Am J Respir Crit Care Med., Vol 181, pp.655-660
9. Corbi G, Bianco A, Turchiarelli V, et al. “Potential mechanisms linking atheroscle-rosis and increased cardiovascular risk in COPD: focus on sirtuins”. Int J Mol Sci 2013;14:12696-713
10. Engler K, et al (2012) “Colonisation with Pseudomonas aeruginosa and antibiotic resistance patterns in COPD patients”. Swiss Med Wkly, 142, pp.1-9.
11. Global Initiative for Chronic Obstructive Lung Disease (2020), Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: 2020 report.
12. Lin S. and et al. (2007), “Sputum bacteriology in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease in Taiwan with an emphasis on Klebsiella pneumoniae and Pseudomonas aeruginosa”, Respirology, 12, pp.81-87.
13. Melissa Lipari (2018), “Adherence to GOLD Guidelines in the Inpatient COPD Population”, Journal of Pharmacy Practice 2018, Vol. 31(1) pp.29-33.
14. Miller J, Edwards LD, Agustí A, et al. “Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort”. Respir Med 2013;107:13, pp.76-84.
15. Phu VD, Wertheim HFL and et al. (2016), “Burden of Hospital Acquired Infections and Antimicrobial Use in Vietnamese Adult Intensive Care Units”, PLoS ONE 11(1): e0147544.